Biotech 365

Main menu

Skip to primary content
Skip to secondary content
  • Biotech 365
    • Contact
    • Offers
  • Biotech Companies
  • Database researchers
    • BioLeads
  • BioMarketplace
  • Biotech Jobs
  • Biopharma News

Tag Archives: beneficial epitope

HIV-Therapeutics – HTI immunogen as therapeutic vaccine curing HIV infections

Posted on 2015-04-09 by Biotech365

HIV-Therapeutics is developing a therapeutic vaccine against HIV infections and AIDS.

HIV-Therapeutics – HTI immunogen as therapeutic vaccine curing HIV infections

hiv-therapeutics Continue reading →

Posted in Biotech Companies, Biotech Companies Spain | Tagged AIDS, beneficial epitope, beneficial epitopes, Christian Brander, HIV, HIV controller, HIV controllers, HIV gag protein, HIV infection, HIV infections, HIV nef protein, HIV pol protein, HIV vif protein, HIV-Therapeutic, HIV-Therapeutics, HIV-Therapeutics - HTI immunogen as therapeutic vaccine curing HIV infections, HIVACAT, HLA-restriction independent, HTI immunogen, Institute for AIDS Research, Institute for AIDS Research IrsiCaixa, IrsiCaixa, Jordi Naval, therapeutic vaccine
Contact                       Offers                      
Proudly powered by WordPress